We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks Input on Cellular, Regenerative Drug Standards
FDA Seeks Input on Cellular, Regenerative Drug Standards
July 26, 2013
The FDA will hold a public workshop on standards development for cellular therapy and regenerative medicines just as drugmakers are yearning for additional clarity on these new types of products.